RESUMO
BACKGROUND: Cerebrotendinous xanthomatosis (CTX) is an autosomal recessively inherited inborn error of metabolism. Neurological symptoms are considered to be a clinical hallmark of untreated adult patients. We describe a 'milder CTX phenotype', without neurological involvement. METHODS: We performed a retrospective patient file study in 79 genetically confirmed Dutch patients with CTX (55 patients aged ≥ 21 years) to study the clinical heterogeneity of CTX. We studied the frequency of adult patients with CTX without neurological involvement at diagnosis, in our Dutch cohort, and included a family from South Africa and patients from Italy, USA, Chile and Asia from the literature. RESULTS: In total, we describe 19 adult patients with CTX from 16 independent families, without neurological symptoms at diagnosis. A relatively small percentage (21%, n = 4) had a history of cataract. The majority, 84% (n = 16), presented with tendon xanthomas as the sole or predominant feature. The majority of patients showed increased plasma cholesterol levels. No correlation was found between this 'milder phenotype', the cholestanol levels and the CYP27A1 genotype. In addition, we describe three novel mutations in the CYP27A1 gene. CONCLUSIONS: This study shows the clinical heterogeneity of CTX, highlighting the existence of a 'milder phenotype', that is without neurological involvement at diagnosis. Adult patients with CTX may present with tendon xanthomas as the sole or predominant feature, mimicking familial hypercholesterolemia. It is important to realize that the absence of neurological symptoms does not rule out the development of future neurological symptoms. As CTX is a treatable disorder, early diagnosis and initiation of treatment when additional clinical signs occur is therefore essential.
Assuntos
Xantomatose Cerebrotendinosa , Adulto , Colestanotriol 26-Mono-Oxigenase/genética , Humanos , Estudos Retrospectivos , Xantomatose Cerebrotendinosa/diagnóstico , Xantomatose Cerebrotendinosa/genéticaRESUMO
Myotonic dystrophy type 2 (DM2) is a rare, autosomal dominant, multisystem disorder with proximal weakness, myotonia, pain and cataract as important symptoms. Given the assumed underreporting of DM2 in the Netherlands combined with the predominant role of pain in DM2 as well as in fibromyalgia syndrome (FMS), we hypothesized there will be an excess prevalence of DM2 in patients with (suspected) FMS. Our objective was to determine the prevalence of DM2 in patients with suspected FMS. A prevalence of 2% was considered a relevant excess frequency. Between November 2011 and April 2014, 398 patients with suspected FMS who had been assessed by a rheumatologist participated in this cross-sectional study. 95% of the study population was female, with a mean age of 42 years. The final ICD-9 diagnoses were collected, in 96% the diagnosis was FMS. 92% met the 2010 American College of Rheumatology (ACR) diagnostic criteria for FMS. A questionnaire including neuromuscular symptoms was completed. Creatine kinase was determined, and genetic testing for DM2 was conducted in all patients. DM2 was established in only one patient (0.25%, 95% CI 0.04-1.4%), thus disapproving our hypothesis of a relevant prevalence of 2%. Our results suggest that patients with suspected FMS should not routinely be tested for DM2.
Assuntos
Fibromialgia/complicações , Fibromialgia/epidemiologia , Distrofia Miotônica/complicações , Distrofia Miotônica/epidemiologia , Adolescente , Adulto , Idoso , Creatina Quinase/metabolismo , Estudos Transversais , Feminino , Fibromialgia/enzimologia , Fibromialgia/genética , Humanos , Masculino , Pessoa de Meia-Idade , Distrofia Miotônica/enzimologia , Distrofia Miotônica/genética , Prevalência , Proteínas de Ligação a RNA/genética , Adulto JovemRESUMO
We here report a 13-year-old Marfan patient who suffered from severe, medication-resistant, intermittent headache, which was provoked when getting into an upright position and immediately relieved by lying down or after intravenous rehydration. The postural benefit and the sudden relief after intravenous hydration suggested (intermittent) intracranial hypotension, although a normal opening pressure on lumbar punction was observed and no cerebrospinal fluid (CSF) leakage was identified. Imaging studies revealed severe dural ectasia at lumbosacral level, and two intradural cysts and two extradural presacral cysts were detected. Most likely, altered hydrodynamics in intra- and extracranial spinal meningeal cysts caused intermittent CSF hypotension above these cysts, resulting in intermittent intracranial hypotension. Surgical marsupialisation of the intradural cysts proved to be effective. This resulted in a significant reduction of the headache during the clinical follow-up of eight years.
Assuntos
Cefaleia/complicações , Síndrome de Marfan/complicações , Doenças da Medula Espinal/complicações , Adolescente , Cistos/complicações , Cistos/cirurgia , Humanos , Hipotensão Intracraniana/etiologia , Imageamento por Ressonância Magnética/métodos , Masculino , Síndrome de Marfan/cirurgia , Mielografia/métodos , Doenças da Medula Espinal/patologia , Doenças da Medula Espinal/cirurgiaRESUMO
An 11-year-old girl was admitted with backpain, weight loss, fatigue and behavioural disturbances, starting seven weeks before admission. Physical examination showed acrodynia, tremor, cachexia, hypertension and extensive gingival ulceration. Routine laboratory tests were normal, except for a CRP of 98 mg/l. Screening tests for recreational drugs as well as antibody assays for HIV, hepatitis B and borrelia burgdorferia were negative. Chest X-ray, brain CAT and MRI scan were all normal. Lumbar puncture didn't show any abnormalities. Eventually a 24-hour urine test confirmed the diagnosis that was suspected by further questioning.
Assuntos
Transtornos Mentais/induzido quimicamente , Intoxicação por Mercúrio/diagnóstico , Dermatopatias/induzido quimicamente , Perda de Dente/induzido quimicamente , Quelantes/uso terapêutico , Criança , Diagnóstico Diferencial , Feminino , Humanos , Transtornos Mentais/diagnóstico , Mercúrio/sangue , Intoxicação por Mercúrio/sangue , Intoxicação por Mercúrio/tratamento farmacológico , Dermatopatias/diagnóstico , Perda de Dente/diagnóstico , Unitiol/uso terapêuticoRESUMO
Cerebrotendinous xanthomatosis (CTX) is an inborn error of bile acid synthesis in which hepatic conversion of cholesterol to cholic and chenodeoxycholic acids is impaired. Patients have abnormal bile alcohols in urine, normal to increased plasma cholesterol concentrations and increased concentrations of plasma cholestanol. Little is known about cholesterol precursors in CTX, however. We studied cholesterol and phytosterol profiles in two siblings with CTX during follow-up. While cholesterol concentrations were low in both patients, plasma cholestanol was 6-fold higher compared to control values. In addition, both siblings had a more than 100-fold increase in 7-dehydrocholesterol (7DHC) and 8-dehydrocholesterol (8DHC). Lathosterol, lanosterol and sitosterol were increased in both patients while concentrations of desmosterol and campesterol were normal. In addition, plasma lathosterol/cholesterol ratios were significantly elevated. After treatment with chenodeoxycholate, both patients showed a marked decrease in cholestanol, 7DHC, 8DHC, lathosterol, lanosterol and sitosterol. In addition, the lathosterol/cholesterol ratio normalized, indicating that overall cholesterol synthesis was sufficiently suppressed. This study shows that elevated cholesterol precursors, other than cholestanol, can be a hallmark for CTX.
Assuntos
Colestanol/sangue , Colesterol/sangue , Xantomatose Cerebrotendinosa/diagnóstico , Biomarcadores/sangue , Biomarcadores/urina , Ácido Quenodesoxicólico/uso terapêutico , Criança , Pré-Escolar , Colestadienóis/sangue , Desidrocolesteróis/sangue , Humanos , Lanosterol/sangue , Masculino , Valor Preditivo dos Testes , Sitosteroides/sangue , Fatores de Tempo , Resultado do Tratamento , Regulação para Cima , Xantomatose Cerebrotendinosa/sangue , Xantomatose Cerebrotendinosa/tratamento farmacológico , Xantomatose Cerebrotendinosa/urinaRESUMO
The authors report four adult-onset ataxia telangiectasia (AT) patients belonging to two families lacking pronounced cerebellar ataxia but displaying distal spinal muscular atrophy. AT was proven by genetic studies showing ATM mutations and a reduced level of ATM. ATM activity, as measured by phosphorylation of p53, was close to normal, indicating that the p53 response is not the only factor in preventing neural damage in anterior horn cells in AT.
Assuntos
Ataxia Telangiectasia/diagnóstico , Ataxia Telangiectasia/genética , Proteínas de Ciclo Celular/genética , Proteínas de Ligação a DNA/genética , Atrofia Muscular Espinal/diagnóstico , Atrofia Muscular Espinal/genética , Proteínas Serina-Treonina Quinases/genética , Proteínas Supressoras de Tumor/genética , Adulto , Ataxia Telangiectasia/complicações , Proteínas Mutadas de Ataxia Telangiectasia , Feminino , Predisposição Genética para Doença/genética , Humanos , Masculino , Atrofia Muscular Espinal/complicaçõesAssuntos
Heterozigoto , Atrofia Muscular Espinal/diagnóstico , Fenótipo , Esteroide Hidroxilases/genética , Xantomatose Cerebrotendinosa/genética , Idade de Início , Alanina/genética , Ácidos e Sais Biliares/sangue , Colestanotriol 26-Mono-Oxigenase , Colestanol/sangue , Colesterol/sangue , Análise Mutacional de DNA , Diagnóstico Diferencial , Erros de Diagnóstico , Diarreia/complicações , Saúde da Família , Feminino , Humanos , Imageamento por Ressonância Magnética/métodos , Pessoa de Meia-Idade , Atrofia Muscular Espinal/genética , Mutação , Prolina/genética , Xantomatose Cerebrotendinosa/sangue , Xantomatose Cerebrotendinosa/diagnóstico , Xantomatose Cerebrotendinosa/patologiaRESUMO
After an uneventful pregnancy a girl was born with serious joint contractures and several fractures of the long bones. The family history was negative for congenital abnormalities. Based on the distinct clinical presentation the diagnosis was 'amyoplasia', which is a partial aplasia of skeletal muscles. The cause of amyoplasia is unknown. As well as the partial muscle aplasia, which is symmetrical and mainly affects the extremities, joint contractures and deep dimples in the skin around the joints are present. Several frequently associated abnormalities have been reported, including abdominal hernias, midface capillary haemangiomas and hypoplastic external genitalia. The condition is always sporadic; there is a striking discordance within monozygotic twins and the offspring of patients is normal. In contrast with the severe neonatal presentation, the clinical prognosis is relatively good owing to intensive multidisciplinary treatment and the normal intelligence of the patients.
Assuntos
Artrogripose/genética , Artrogripose/patologia , Contratura , Doenças em Gêmeos , Expressão Facial , Feminino , Humanos , Lactente , Recém-Nascido , Deformidades Congênitas dos Membros , Músculos/anormalidades , PrognósticoRESUMO
Follow-up investigations were undertaken on a previously reported patient who had severe familial giant cell hepatitis in infancy associated with substantially increased urinary excretion of bile alcohol glucuronides. By the age of 11 years, he had developed a profile of cholanoids in plasma and urine that closely resembled the pattern seen in cerebrotendinous xanthomatosis (CTX). Sequencing of the sterol 27-hydroxylase gene (CYP27A) showed that he was homozygous for a deletion (525/526delG) that causes a frameshift and a premature stop codon. This genotype has previously been described in an adult female with classical symptoms of CTX (tendon xanthomata, cataracts and deteriorating cognitive function). A review of past medical histories of a group of patients with CTX revealed that prolonged neonatal cholestatic jaundice was common. The family histories also revealed fetal and neonatal deaths among siblings of patients with CTX. We conclude that defective activity of cholesterol 27-hydroxylase can lead to neonatal cholestatic jaundice ('hepatitis of infancy'), which may be self-limiting. After a latent period, however, progressive accumulation of cholesterol and cholestanol can lead to the xanthomata, neurodegeneration, cataracts and atherosclerosis that are typical of CTX.
Assuntos
Hepatite/genética , Mutação/genética , Esteroide Hidroxilases/genética , Xantomatose Cerebrotendinosa/genética , Adolescente , Adulto , Ácido Quenodesoxicólico/sangue , Colestanotriol 26-Mono-Oxigenase , Colestanóis/urina , Colestase/etiologia , Ácido Cólico/sangue , DNA/genética , Éxons , Cromatografia Gasosa-Espectrometria de Massas , Hepatite/complicações , Humanos , Masculino , Xantomatose Cerebrotendinosa/complicaçõesRESUMO
A 24-year-old woman and a 13-year-old boy had suffered from diarrhoea, walking disorders, visual complaints and other complaints for many years. Once the suspicion of cerebrotendinous xanthomatosis (CTX) had been confirmed with biochemical and genetic tests and treatment with chenodeoxycholic acid had been started, the diarrhoea disappeared and the neurological symptoms lessened. CTX is a rare, autosomal recessive metabolic disease. The clinical hallmarks are: bilateral juvenile cataract, chronic diarrhoea, progressive neurological symptoms and signs, and tendon xanthomas. The phenotypic variability often hinders the clinical diagnosis. The biochemical diagnosis can be made by determining the serum cholestanol level and the excretion of urinary bile alcohols, followed by a mutation analysis. CTX is a treatable disease and therefore an early diagnosis is important.
Assuntos
Xantomatose Cerebrotendinosa , Adolescente , Adulto , Catarata/genética , Colestanóis/urina , Colesterol/sangue , Aberrações Cromossômicas , Transtornos Cromossômicos , Cromossomos Humanos Par 2/genética , Análise Mutacional de DNA , Diagnóstico Diferencial , Diarreia/genética , Feminino , Transtornos Neurológicos da Marcha/genética , Humanos , Masculino , Xantomatose Cerebrotendinosa/diagnóstico , Xantomatose Cerebrotendinosa/genéticaRESUMO
We investigated two brothers with Scheie syndrome whose only complaint was exercise intolerance. In the quadriceps muscle biopsy of both patients, between the normal muscle fibres an increased number of markedly swollen periodic acid-Schiff-positive fibroblasts were seen. Ultrastructurally, these cells showed an accumulation of enlarged lysosomes, partly filled with electro-dense material. We hypothesize that the accumulation of pathological fibroblasts may interfere with intramuscular force transmission resulting in exercise intolerance.
Assuntos
Mucopolissacaridose I/genética , Debilidade Muscular/genética , Adolescente , Adulto , Biópsia , Diagnóstico Diferencial , Eletromiografia , Matriz Extracelular/patologia , Fibroblastos/patologia , Humanos , Masculino , Microscopia Eletrônica , Mucopolissacaridose I/diagnóstico , Mucopolissacaridose I/patologia , Debilidade Muscular/diagnóstico , Debilidade Muscular/patologia , Músculo Esquelético/patologia , Vacúolos/patologiaRESUMO
An 8 year-old boy with X-ALD under treatment with simvastatin developed a severe adverse reaction when the dose of his other medication, zuclopenthixol was increased. Both drugs were withdrawn after a diagnosis of neuroleptic malignant syndrome was made.
Assuntos
Adrenoleucodistrofia/genética , Antipsicóticos/efeitos adversos , Clopentixol/efeitos adversos , Síndrome Maligna Neuroléptica/genética , Adrenoleucodistrofia/complicações , Antipsicóticos/administração & dosagem , Antipsicóticos/uso terapêutico , Criança , Transtornos do Comportamento Infantil/tratamento farmacológico , Transtornos do Comportamento Infantil/psicologia , Clopentixol/administração & dosagem , Clopentixol/uso terapêutico , Humanos , Masculino , Síndrome Maligna Neuroléptica/complicações , Sinvastatina/uso terapêuticoRESUMO
PURPOSE: To describe imaging findings and their neuropathologic correlate in patients with cerebrotendinous xanthomatosis (CTX). MATERIALS AND METHODS: Computed tomographic (CT) and magnetic resonance (MR) images in 24 patients with symptoms (mean age at time of imaging, 37 years; mean disease duration, 18 years) were reviewed for site and frequency of brain, spinal cord, and Achilles tendon involvement. Two patients died, and imaging findings were compared with postmortem neuropathologic findings. RESULTS: Apart from nonspecific supratentorial atrophy and deep white matter changes, more typical hyperintense lesions were seen on T2-weighted images in the dentate nucleus (in 79% of patients), globus pallidus, substantia nigra, and inferior olive and extended into adjacent white matter as disease progressed. In these locations, lipid crystal clefts and perivascular macrophages, neuronal loss, demyelination, fibrosis, and reactive astrocytosis were found at microscopic examination. Hypointensity was sometimes found on T2-weighted images in the dentate nucleus and was related to deposition of hemosiderin and calcifications. CT depicted fewer lesions; all had low attenuation, except for the calcifications. Spinal cord MR imaging revealed increased signal intensity in the lateral and dorsal columns on T2-weighted images. Achilles tendon xanthomas displayed intermediate signal intensity on T1- and T2-weighted images. CONCLUSION: The typical pattern of MR imaging findings reflects the classic histopathologic findings and should prompt the diagnosis of CTX.
Assuntos
Imageamento por Ressonância Magnética/métodos , Xantomatose Cerebrotendinosa/patologia , Adolescente , Adulto , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Tomografia Computadorizada por Raios X , Xantomatose Cerebrotendinosa/diagnóstico por imagemRESUMO
Neuromuscular characteristics were documented in ten patients with biochemically and genetically confirmed cerebrotendinous xanthomatosis. An array of genotypes was found in these patients. Only one patient complained of muscle weakness, while clinical signs of peripheral neuropathy were present in six patients. Electromyogram showed predominantly axonal neuropathy in seven patients. Neurogenic changes were seen in muscle biopsies of nine patients. Sural nerve biopsies of three patients showed features of axonal neuropathy. In addition, in one patient, extensive onion bulb formation was seen, which is indicative of a primarily demyelinating process. Five patients had normal mitochondrial respiratory chain enzyme activity. It is concluded that myopathy is not a feature of cerebrotendinous xanthomatosis and that the most prominent neuromuscular abnormality is sensorimotor axonal polyneuropathy.
Assuntos
Músculo Esquelético/patologia , Músculo Esquelético/fisiopatologia , Fibras Nervosas/patologia , Xantomatose Cerebrotendinosa/patologia , Xantomatose Cerebrotendinosa/fisiopatologia , Adulto , Axônios/patologia , Axônios/ultraestrutura , Biópsia , Colestanotriol 26-Mono-Oxigenase , Sistema Enzimático do Citocromo P-450/genética , Eletromiografia , Transporte de Elétrons , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mitocôndrias Musculares/enzimologia , Mitocôndrias Musculares/ultraestrutura , Músculo Esquelético/ultraestrutura , Fibras Nervosas/ultraestrutura , Esteroide Hidroxilases/genética , Nervo Sural/patologia , Nervo Sural/ultraestrutura , Xantomatose Cerebrotendinosa/genéticaAssuntos
Doença da Arranhadura de Gato/diagnóstico , Polirradiculoneuropatia Desmielinizante Inflamatória Crônica/diagnóstico , Animais , Axônios/patologia , Biópsia , Doença da Arranhadura de Gato/patologia , Gatos , Pré-Escolar , Humanos , Masculino , Fibras Nervosas Mielinizadas/patologia , Exame Neurológico , Polirradiculoneuropatia Desmielinizante Inflamatória Crônica/patologia , Nervo Sural/patologiaRESUMO
Cerebrotendinous xanthomatosis (CTX) is a lipid storage disease caused by a deficiency of the mitochondrial enzyme 27-sterol hydroxylase (CYP 27), due to mutations in its gene. In this study we report on mutations in 58 patients with CTX out of 32 unrelated families. Eight of these were novel mutations, two of which were found together with two already known pathogenic mutations. Twelve mutations found in this patient group have been described in the literature. In the patients from 31 families, mutations were found in both alleles. In the literature, 28 mutations in 67 patients with CTX out of 44 families have been described. Pooling our patient group and the patients from the literature together, 37 different mutations in 125 patients out of 74 families were obtained. Identical mutations have been found in families from different ethnic backgrounds. In 41% of all the patients, CYP 27 gene mutations are found in the region of exons 6-8. This region encodes for adrenodoxin and haem binding sites of the protein. Of these 125 patients, a genotype-phenotype analysis was done for 79 homozygous patients harbouring 23 different mutations, out of 45 families. The patients with compound heterozygous mutations were left out of the genotype-phenotype analysis. The genotype-phenotype analysis did not reveal any correlation.
Assuntos
Sistema Enzimático do Citocromo P-450/genética , Mutação , Esteroide Hidroxilases/genética , Xantomatose Cerebrotendinosa/genética , Xantomatose Cerebrotendinosa/patologia , Adolescente , Adulto , Idade de Início , Substituição de Aminoácidos , Encéfalo/patologia , Criança , China , Colestanotriol 26-Mono-Oxigenase , Etnicidade/genética , Europa (Continente) , Éxons , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Países Baixos , Mutação Puntual , Deleção de Sequência , Tunísia , Xantomatose Cerebrotendinosa/fisiopatologiaRESUMO
BACKGROUND: Cerebrotendinous xanthomatosis (CTX) is an autosomal recessive disorder of bile acid synthesis. A diagnosis of CTX should be considered in patients with premature bilateral cataracts, intractable diarrhea, neurological signs and symptoms, and tendon xanthomas, especially in the Achilles tendons. The prevalence of these signs and symptoms increases with age. OBJECTIVES: To investigate signs and symptoms, age at onset, and age at diagnosis in 32 patients with biochemically and genetically confirmed CTX, and to compare this clinical spectrum with reports in the literature. METHODS: Retrospective analysis of records of all patients with CTX at our hospital (27 adults and 5 children). After a MEDLINE search in the English, French, and German literature, 181 patients with CTX (165 adults and 16 children) were identified worldwide. RESULTS: Of our 32 patients with CTX, 31 (97%) had cataracts and neurological signs and symptoms, predominantly pyramidal signs (26 [81%]); 21 (66%) had low intelligence and 18 (56%) had cerebellar signs. Only 13 (41%) had visible or palpable tendon xanthomas at the time of diagnosis. In total, 16 patients (50%) had chronic, intractable diarrhea that started in childhood. These findings were in contrast with the literature, where tendon xanthomas were reported in 89% and diarrhea in only 2 patients. CONCLUSIONS: We believe that CTX is underdiagnosed worldwide. We recommend that the presence of 2 of the 4 clinical hallmarks of CTX prompt thorough metabolic screening, including determination of urine bile alcohol excretion and serum cholestanol level, because CTX is a treatable disease.
Assuntos
Diarreia/epidemiologia , Xantomatose Cerebrotendinosa/diagnóstico , Xantomatose Cerebrotendinosa/epidemiologia , Xantomatose/diagnóstico , Xantomatose/epidemiologia , Adolescente , Adulto , Idade de Início , Criança , Colestanol/sangue , Colestanóis/urina , Comorbidade , Diagnóstico Diferencial , Feminino , Genes Recessivos , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Estudos Retrospectivos , Xantomatose Cerebrotendinosa/fisiopatologiaRESUMO
We describe seven Dutch patients from six families with a slowly progressive, mainly spinal cord syndrome that remained for many years the sole expression of cerebrotendinous xanthomatosis (CTX). MRI demonstrated white matter abnormalities in the lateral and dorsal columns of the spinal cord. Post-mortem examination of one of the patients showed extensive myelin loss in these columns. An array of genotypes was found in these patients. We conclude that 'spinal xanthomatosis' is a clinical and radiological separate entity of CTX that should be included in the differential diagnosis of 'chronic myelopathy'.
Assuntos
Sistema Enzimático do Citocromo P-450/genética , Doenças da Medula Espinal/genética , Doenças da Medula Espinal/patologia , Esteroide Hidroxilases/genética , Xantomatose Cerebrotendinosa/genética , Xantomatose Cerebrotendinosa/patologia , Adulto , Idade de Início , Cerebelo/patologia , Colestanotriol 26-Mono-Oxigenase , Éxons , Feminino , Genótipo , Humanos , Íntrons , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Mutação Puntual , Medula Espinal/patologiaRESUMO
The effects of combination therapy with chenodeoxycholic acid (CDCA) and simvastatin on serum cholestanol, low-density lipoprotein (LDL) cholesterol, and lathosterol levels were investigated in seven adult patients with cerebrotendinous xanthomatosis (CTX) who were on long-term treatment with CDCA. The patients were treated with a combination of CDCA 750 mg daily and an increasing dose of simvastatin from 10 mg to 40 mg daily for a period of 6 months. We found a significant effect of this combination therapy compared with CDCA alone in terms of decreasing the serum cholestanol and LDL cholesterol levels, particularly with a daily dose of 40 mg simvastatin. The mean cholestanol level decreased from 9.27 micromol/L (baseline) to 6.69 micromol/L (40 mg simvastatin), while the mean LDL cholesterol level decreased from 5.08 mmol/L (baseline) to 3.04 mmol/L (40 mg simvastatin). No side effects were reported, and there were no effects on the clinical condition, cerebral magnetic resonance imaging (MRI), visual evoked potentials, and electroencephalographic features. We conclude that a combination of 750 mg CDCA and 40 mg simvastatin daily is effective to further reduce serum cholestanol, LDL cholesterol, and lathosterol in adult CTX patients treated with long-term CDCA. Whether this combination treatment will be effective for the long-term prevention of neurological deterioration and atherosclerosis remains to be established.
Assuntos
Anticolesterolemiantes/uso terapêutico , Ácido Quenodesoxicólico/uso terapêutico , Fármacos Gastrointestinais/uso terapêutico , Sinvastatina/uso terapêutico , Xantomatose Cerebrotendinosa/tratamento farmacológico , Adulto , Colesterol/sangue , Feminino , Humanos , Testes de Função Renal , Lipídeos/sangue , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Xantomatose Cerebrotendinosa/sangueRESUMO
UNLABELLED: The clinical spectrum and the effects of treatment over a period of 5 years in five children with cerebrotendinous xanthomatosis (CTX) are described. In all children biochemical, neuroradiological, and neurophysiological studies were done. CTX was diagnosed and effects of therapy were evaluated by determination of the serum cholestanol/cholesterol ratio (CCR) and the urinary excretion of bile alcohols. All children were treated with chenodeoxycholic acid (15 mg/kg/day) in three divided oral doses. Diarrhoea and juvenile cataract were the main clinical features. Psychomotor retardation, pyramidal and cerebellar signs were also found. After starting treatment, biochemical abnormalities normalized and diarrhoea disappeared. After 1 year of therapy there was no further delay in motor development, and in three children the intelligence quotient improved. EEG abnormalities disappeared. After 5 years of therapy the children are in a stable clinical condition. CONCLUSION: The clinical, biochemical and neurophysiological abnormalities in five children with CTX showed a remarkable improvement after starting treatment with chenodeoxycholic acid. The early diagnosis of CTX and the start of treatment with chenodeoxycholic acid has prevented neurological deterioration for a period of 5 years.